This webinar will cover the law on confidentiality of substance use disorder patient records under 42 CFR part 2. This law was previously known as the confidentiality of drug abuse and alcohol abuse records.
The new law originally was effective in 2017 and a second law was effective February 2, 2018. Updates occurred in 2020 and hospitals are still struggling to determine what they need to do to meet compliance.
Anyone or any facility that is subject to these requirements needs to attend this webinar. All hospitals should have a policy and this program will address what needs to be in the policy. This is true even for hospitals that do not have dedicated units to treat patients with drug and alcohol problems, now known as substance abuse disorders. Changes and updates implemented in 2020 will also be discussed.
The webinar will discuss what is required of part 2 programs. A facility that receives federal assistance (such as Medicare) and holds itself out as providing substance use disorder diagnosis, treatment, or referral must follow these extensive regulations. They address the notice that must be given to the patient. It discusses patient access to medical records and what must be in the consent form.
It discusses research, closure of a program, new definitions, minors, decease patient records, security of medical records, disclosure, when disclosure is prohibited, and more.
The new law originally was effective in 2017 and a second law was effective February 2, 2018. Updates occurred in 2020 and hospitals are still struggling to determine what they need to do to meet compliance.
Anyone or any facility that is subject to these requirements needs to attend this webinar. All hospitals should have a policy and this program will address what needs to be in the policy. This is true even for hospitals that do not have dedicated units to treat patients with drug and alcohol problems, now known as substance abuse disorders. Changes and updates implemented in 2020 will also be discussed.
The webinar will discuss what is required of part 2 programs. A facility that receives federal assistance (such as Medicare) and holds itself out as providing substance use disorder diagnosis, treatment, or referral must follow these extensive regulations. They address the notice that must be given to the patient. It discusses patient access to medical records and what must be in the consent form.
It discusses research, closure of a program, new definitions, minors, decease patient records, security of medical records, disclosure, when disclosure is prohibited, and more.
Why you should Attend:
Uncertainty, Unawareness of federal regulations regarding Substance Use Disorder medical records.Areas Covered in the Session:
- Introduction and history
- Substance use disorder patient records
- How to locate a copy of the law
- Substance use disorder data
- Purpose and need of new law
- Who is subjected to the law under part 2
- 2018 changes: disclosures with patient consent, audit, and evaluation, abbreviated notice on redisclosure, etc.
- 2020 changes regarding disclosures
- Sub-regulatory guidance
- Notice to patients of confidentiality requirements
- Patient access to medical records and restrictions on use
- Reports of violations or penalties
- General Provisions
- Definitions
- Minor patient
- Deceased patient
- Security of medical records
- Restrictions on disclosure
- Crimes on the premises and child abuse reports
- Prohibitions on re-disclosure
- Relationship to state laws
- Disclosures with consent
- Disclosures to the criminal justice system
- Disclosure without consent
- Medical emergencies
- Court orders
- Informants and undercover agents
- Closing a program
- Research
- Audits and evaluation
- FAQs
- OCR and HIPAA and mental health records
Speaker
Laura A. Dixon served as the Director, of Facility Patient Safety and Risk Management and Operations for COPIC from 2014 to 2020. In her role, Ms. Dixon provided patient safety and risk management consultation and training to facilities, practitioners, and staff in multiple states. Such services included the creation of presentations on risk management topics, assessment of healthcare facilities; and development of programs and compilation of reference materials that complement physician-oriented products.Ms. Dixon has more than twenty years of clinical experience in acute care facilities, including critical care, coronary care, peri-operative services, and pain management. Prior to joining COPIC, she served as the Director of, Western Region, Patient Safety, and Risk Management for The Doctors Company, Napa, California. In this capacity, she provided patient safety and risk management consultation to the physicians and staff in the western United States. Ms. Dixon’s legal experience includes medical malpractice insurance defense and representation of nurses before the Colorado Board of Nursing.
As a registered nurse and attorney, Laura holds a Bachelor of Science degree from Regis University, RECEP of Denver, a Doctor of Jurisprudence degree from Drake University College of Law, Des Moines, Iowa, and a Registered Nurse Diploma from Saint Luke’s School Professional Nursing, Cedar Rapids, Iowa. She is licensed to practice law in Colorado and California.
Who Should Attend
- Staff that care for of patients in a federally assisted program and who holds themselves out as providing care and treatment to patients with a substance use disorder (SUD).
- Program directors
- Risk managers
- Health information management director and staff
- Nurses
- Physicians
- Mid-level providers
- Compliance officers
- Hospital legal counsel.
- Clinicians who use a controlled substance for detoxification or maintenance treatment of withdrawal of a SUD
